105 related articles for article (PubMed ID: 7933456)
21. Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
Fogari R; Zoppi A; Malamani GD; Marasi G; Vanasia A; Villa G
Br J Clin Pharmacol; 1995 May; 39(5):471-6. PubMed ID: 7669481
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
23. Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension.
Christogiannis LG; Kostapanos MS; Tellis CC; Milionis HJ; Tselepis AD; Elisaf MS
J Hum Hypertens; 2013 Jan; 27(1):44-50. PubMed ID: 22129607
[TBL] [Abstract][Full Text] [Related]
24. Serum lipids & lipoprotein profiles of cigarette smokers & passive smokers.
Whig J; Singh CB; Soni GL; Bansal AK
Indian J Med Res; 1992 Oct; 96():282-7. PubMed ID: 1459670
[TBL] [Abstract][Full Text] [Related]
25. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
[TBL] [Abstract][Full Text] [Related]
26. Blood glucose levels in hypertensive patients during treatment with different antihypertensive agents.
Ahaneku JE
Acta Med Okayama; 1996 Apr; 50(2):107-10. PubMed ID: 8744936
[TBL] [Abstract][Full Text] [Related]
27. Clinically additive effect between doxazosin and amlodipine in the treatment of essential hypertension.
Nalbantgil S; Nalbantgil I; Onder R
Am J Hypertens; 2000 Aug; 13(8):921-6. PubMed ID: 10950401
[TBL] [Abstract][Full Text] [Related]
28. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A
Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337
[TBL] [Abstract][Full Text] [Related]
29. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
[TBL] [Abstract][Full Text] [Related]
30. Effect of isradipine, a new calcium antagonist on the lipid profile in patients with hypertension.
Samuel P
Cor Vasa; 1990; 32(2 Suppl 1):35-41. PubMed ID: 2143459
[TBL] [Abstract][Full Text] [Related]
31. INFLUENCE OF BASELINE VALUES ON LIPIDS, LIPOPROTEINS AND FIBRINOLYTIC PARAMETERS DURING AMLODIPINE TREATMENT OF HYPERTENSION IN JAPANESE PATIENTS.
Ahaneku JE; Sakata K; Urano T; Takada Y; Takada A
Pharmacol Res; 2000 Jan; 41(1):73-77. PubMed ID: 10712829
[TBL] [Abstract][Full Text] [Related]
32. Effects of amlodipine on plasma lipid and lipoprotein levels in hypertensive patients.
Ahaneku JE; Taylor GO; Agbedana EO; Walker O; Sowunmi A; Salako LA
J Intern Med; 1992 Dec; 232(6):489-91. PubMed ID: 1474348
[TBL] [Abstract][Full Text] [Related]
33. Influence of baseline values on lipids, lipoproteins and fibrinolytic parameters during treatment of hypertension with cilnidipine.
Ahaneku JE; Sakata K; Urano T; Takada Y; Takada A
Pharmacol Res; 2000 Jan; 41(1):81-4. PubMed ID: 10600273
[TBL] [Abstract][Full Text] [Related]
34. Influence of baseline values. I: Effects on plasma total cholesterol and triglyceride levels during doxazosin treatment for hypertension.
Ahaneku JE; Taylor GO; Agbedana EO; Walker O; Salako LA
Int J Clin Pharmacol Res; 1998; 18(4):159-63. PubMed ID: 10052025
[TBL] [Abstract][Full Text] [Related]
35. Plasma lipids and lipoprotein cholesterol in undernourished diabetic subjects and adults with protein energy malnutrition.
Das S; Tripathy BB; Samal KC; Panda NC
Diabetes Care; 1984; 7(6):579-86. PubMed ID: 6439533
[TBL] [Abstract][Full Text] [Related]
36. [Comparative evaluation of the anti-hypertensive effect of moduretic and thiazides].
Rosenfeld JB
Schweiz Med Wochenschr; 1980 Oct; 110(41):1498-501. PubMed ID: 7423177
[TBL] [Abstract][Full Text] [Related]
37. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
Spence JD; Huff M; Barnett PA
Can J Clin Pharmacol; 2000; 7(1):32-7. PubMed ID: 10822211
[TBL] [Abstract][Full Text] [Related]
38. Doxazosin and hydrochlorothiazide equally affect arterial wall thickness in hypertensive males with hypercholesterolaemia (the DAPHNE study). Doxazosin Atherosclerosis Progression Study in Hypertensives in the Netherlands.
Hoogerbrugge N; de Groot E; de Heide LH; de Ridder MA; Birkenhägeri JC; Stijnen T; Jansen H
Neth J Med; 2002 Oct; 60(9):354-61. PubMed ID: 12572707
[TBL] [Abstract][Full Text] [Related]
39. Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension.
Pool JL; Taylor AA; Nelson EB
Am J Med; 1989 Aug; 87(2A):57S-61S. PubMed ID: 2569825
[TBL] [Abstract][Full Text] [Related]
40. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
Talseth T; Westlie L; Daae LN
J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
